Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 63.99

+4.7%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: software salesperson who wrote (52129)	12/23/2024 10:52:08 AM
From: software salesperson	Read Replies (1) of 52153

Mark Cuban’s interview with Eric Topol A far-reaching discussion on how Cuban and his partner are looking to disrupt the healthcare industry thru Cost Plus. very educational. Hopefully someone can take advantage of their knowledge on how they are either doing so or are planning to do so by eliminating pricing opaqueness, thereby saving the consumer $. Describes in detail how PBMs, insurance companies, hospitals, and transaction and administrative processors operate. Cuban was anticipating questions too quickly to be making up stuff on the fly. costplusdrugs.com youtube.com en.wikipedia.org - - profile of his partner We’ll see how successful they will be.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next